Inhibition of liver RNA breakdown during acute inflammation in the rat.
Liver RNA- and protein-degradation rates were measured after the induction of acute inflammation in the rat. A preliminary study determined changes in hepatic RNA and protein content 12, 18 and 24 h after a turpentine oil injection. The RNA content in turpentine-treated rats compared with pair-fed animals increased significantly and sharply from 12 h (+ 11%) to 18 h (+ 32%) and slightly thereafter (+ 37% at 24 h). The liver protein content was significantly enhanced only at 24 h (+ 11%) in response to inflammation. RNA-degradation rates were determined in livers perfused cyclically in situ for 15 min by measuring the accumulation of radioactive cytidine in the medium 60 h after in vivo labelling of RNA by [5-3H]cytidine instead of [6-14C]orotic acid, the most commonly used radioactive marker. Several validation procedures showed that the method employed was a valid alternative to the use of radioactive orotic acid. RNA-degradation rates, which mainly reflect rRNA breakdown, were significantly lower in the turpentine-treated rats than in respective pair-fed animals at 18 and 24 h (57 and 45% decrease respectively). Proteolysis rates measured at 24 h together with RNA breakdown by valine accumulation in the perfusion medium were not modified after turpentine treatment. The main factors known to regulate RNA degradation (amino acids, insulin/glucagon ratio) were measured in the portal blood 24 h after induction of acute inflammation. Of the known regulatory amino acids, only glutamine and to a lesser extent methionine were increased in the turpentine-treated rats as compared with their pair-fed counterparts. The insulin/glucagon molar ratio was similar in both groups. In conclusion, the reduced breakdown of RNA, especially rRNA, is largely responsible for the accumulation of hepatic RNA during acute inflammation. This inhibition of RNA degradation could possibly be related to the increase in glutamine.
Saadane
A
A
Laboratoire de Biologie Cellulaire, Unité 327 de l'Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté de Médecine Xavier-Bichat, Université, Paris, France.
Neveux
N
N
Feldmann
G
G
Lardeux
B
B
Bleiberg-Daniel
F
F
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D003562:Cytidine; D005934:Glucagon / Q000378:metabolism; D006505:Hepatitis / Q000378:metabolism*; D006868:Hydrolysis; D007328:Insulin / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014316:Tritium
D000596:Amino Acids; D007328:Insulin; D011506:Proteins; D014316:Tritium; D003562:Cytidine; D012313:RNA; D005934:Glucagon